Jacob Abraham, Igarashi Suzu, Platto Terry, Khan Rihan, Jain Richa
University of Arizona Ear Institute, University of Arizona Department of Otolaryngology, University of Arizona Cancer Center, The University of Arizona Bio5 Institute, Tucson, Arizona, USA
University of Arizona Ear Institute, University of Arizona Department of Otolaryngology, University of Arizona Cancer Center, Tucson, Arizona, USA.
Ann Otol Rhinol Laryngol. 2015 Oct;124(10):834-40. doi: 10.1177/0003489415588128. Epub 2015 May 27.
Nearly all radiated vestibular schwannomas (VS) have solid tissue remaining at the radiation bed. The viability and proliferation capacity of this tissue has never been objectively assessed. The goals of our study were to (1) determine whether this tissue retains the morphological and immunohistochemical features of VS and (2) evaluate whether the tissue is capable of proliferation in cell culture.
Case history, magnetic resonance imaging (MRI), cell culture, histology, and immunohistochemistry.
We report the first case of a post-radiated, sporadic VS patient whose non-growing, residual MR-enhancing solid tissue was examined histologically and in cell culture. These cells were architecturally identical to non-radiated VS, had a Ki67 proliferative index similar to non-radiated sporadic and NF2-associated VS, were S100 positive, and grew in culture with kinetics comparable to non-radiated VS.
The long-term risk for delayed tumor growth and/or secondary malignancy in radiated VS patients is unknown. Because the average life span in the United States is nearly 80 years, patients should be informed that (1) residual VS cells are viable even when tumors appear to be non-growing on MRI, (2) post-radiation surveillance imaging is required indefinitely, and (3) radiation may incur more risk in those patients with life expectancy>20-25 years.
几乎所有接受放疗的前庭神经鞘瘤(VS)在放疗部位均残留有实性组织。该组织的生存能力和增殖能力从未得到过客观评估。我们研究的目的是:(1)确定该组织是否保留VS的形态学和免疫组化特征;(2)评估该组织在细胞培养中是否具有增殖能力。
病史、磁共振成像(MRI)、细胞培养、组织学和免疫组化。
我们报告了首例接受放疗的散发性VS患者,对其非生长性、残留的磁共振增强实性组织进行了组织学检查和细胞培养。这些细胞在结构上与未接受放疗的VS相同,Ki67增殖指数与未接受放疗的散发性和NF2相关VS相似,S100呈阳性,在培养中的生长动力学与未接受放疗的VS相当。
接受放疗的VS患者出现延迟肿瘤生长和/或继发性恶性肿瘤的长期风险尚不清楚。由于美国的平均寿命接近80岁,应告知患者:(1)即使肿瘤在MRI上看似不生长,残留的VS细胞仍具有活力;(2)放疗后需要无限期进行监测成像;(3)对于预期寿命>20 - 25岁的患者,放疗可能会带来更多风险。